Last updated: May 25, 2026
GoloDirsen (golodirsen) Supplier Landscape: Who Manufactures, Fills, and Supplies the Drug Product?
GOLodirsen supplier sourcing is tied to the drug’s FDA approval chain and the manufacturer listed for commercial product. For “golodirsen” (Vyondys 53) the supply is concentrated in the Sarepta Therapeutics commercial manufacturing and its contract manufacturing network. A complete, audit-grade list of named suppliers (API, fill-finish, packaging components, and contract manufacturers) is not available in the provided information, so a precise supplier roster cannot be produced.
Who are the contract manufacturers and fill-finish suppliers for golodirsen (Vyondys 53)?
Answer: Not determinable from the information provided.
What suppliers typically touch golodirsen’s value chain (API, drug product, packaging)
- API manufacturer (active ingredient synthesis and purification)
- Drug product manufacturer (formulation and aseptic filling)
- Fill-finish provider (vial preparation, sterile filling, lyophilization vs liquid filling depending on the product form)
- Primary packaging suppliers (vials, stoppers, seals)
- Labeling and carton suppliers (secondary packaging and distribution kits)
Which companies supply golodirsen (Vyondys 53) to distributors and specialty pharmacies?
Answer: Not determinable from the information provided.
What is the Orange Book status of golodirsen and does it affect supplier availability?
Answer: Not determinable from the information provided.
What patents protect golodirsen formulations and manufacturing methods that limit alternate suppliers?
Answer: Not determinable from the information provided.
When does golodirsen lose exclusivity and how does that change supplier options?
Answer: Not determinable from the information provided.
Are there generic or biosimilar suppliers for golodirsen, and which companies are closest to entry?
Answer: Not determinable from the information provided.
What FDA manufacturing sites are responsible for golodirsen supply?
Answer: Not determinable from the information provided.
How many suppliers exist for golodirsen (Vyondys 53) and what is the risk of single-source dependence?
Answer: Not determinable from the information provided.
Which raw-material and component suppliers are critical for golodirsen production?
Answer: Not determinable from the information provided.
Key Takeaways
- GoloDirsen/golodirsen commercial supply is tied to the FDA-listed manufacturer(s) and contract manufacturing chain.
- A complete supplier list for API, drug product, fill-finish, and packaging cannot be compiled from the information provided.
- Supplier count, single-source risk, and component-level dependencies require manufacturer and FDA manufacturing site specifics that are not available here.
FAQs
- Is golodirsen manufactured by Sarepta in-house or via contract manufacturing? Not determinable from the information provided.
- Which company supplies the aseptic fill-finish for Vyondys 53? Not determinable from the information provided.
- Do alternate manufacturers supply vials, stoppers, and seals for golodirsen? Not determinable from the information provided.
- Are there pending ANDA-style entrants for golodirsen supply alternatives? Not determinable from the information provided.
- How does manufacturing site registration affect golodirsen availability during capacity constraints? Not determinable from the information provided.
References (APA)
No sources were provided to cite.
